Lymphedema of Upper Arm

4

Review clinical trials related to Lymphedema of Upper Arm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Screening For BCRL In Targeted Therapy For Breast Cancer

This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer. A Perometer and Sozo devise will be used to measure volume changes

Participants needed: 261
Trial details
Age: 18-80Biological sex: FemaleType: ObservationalSponsor: Massachusetts General HospitalUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Subjects who are receiving treatment in the MGH Breast Cancer Center who are enr... [+5]

Status: Recruiting

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

Participants needed: 285
Trial details
Phase: Phase 3Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Nov 10, 2025Locations: 7
Eligibility criteria

Female sex [+3]

Male sex [+8]

Status: Recruiting

The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema

This study assesses the performance of robot-assisted microsurgery. Lymphaticovenous anastomosis (LVA) is the most difficult procedure in microsurgery at this moment. The LVA technique is applied to treat for example breast cancer-related lymphedema (BCRL). Therefore, this LVA procedure is compared using a manual expert and the same expert applying robot-assisted LVA.

Participants needed: 60
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Maastricht University Medical CenterUpdated: Aug 1, 2024Locations: 1
Eligibility criteria

Female gender; [+4]

Male gender; [+7]

Status: Recruiting

Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema

Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion. Photobiomodulation therapy (PBMT) is a non-invasive therapy based on the application of visible and/or near-infrared light produced by a laser diode or a light-emitting diode. The scientifically proven biologic effects of PBM are improved wound healing, and a reduction in pain, inflammation, and oedema. Therefore, the aim of this study is to evaluate the effectiveness of PBMT on the management of BCRL.

Participants needed: 104
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Jessa HospitalUpdated: Feb 28, 2023Locations: 2
Eligibility criteria

Diagnosed with breast cancer [+6]

Metastatic disease [+6]